I'm sure some of you have seen the website by dynavax. I think they will be the company to watch....I wrote to them inquiring about the future of clinical trials on the peanut vaccine....this is the response I got. Just wanted to share it with all of you :
Dear Mrs. Farkas,
Thank you for your interest in the vaccine program at Dynavax. At this stage we only have preclinical research activities that are ongoing regarding peanut allergy. Depending on the outcome of these studies we may decide to move into the clinic but this will not occur in the immediate future. I will advise that you check with us again towards the end of the year.
As you are probably aware some encouraging results have been reported recently with anti IgE monoclonal antibodies and you may want to check whether clinical studies are being scheduled with these products. I do understand your concern for your child and wish I could be of more help.
Best of luck and kind regards,
Daniel Gennevois, M.D.
Dynavax Technologies
750 Potter Street
Berkeley, CA 94710
(510) 450 7121
Stay safe!
allison
Thanks for posting the info. I have not heard of Dynavax until now. Anyway, that
made my day, I'm always hopeful about new research.
Holly
Is this correct....there are currently TWO different peanut allergy remedies being worked on right now - a peanut vaccine AND the TNX 901 medicine that the drug companies are arguing over. The vaccine has not gone to clinical trial yet but there have been some articles that it may be ready to in the next couple years. The 901 has gone to clinical trial and is currently on hold.....correct?? I just wanted to clarify to make sure I'm not confused!
the tnx-901 trials have been continued for another 40 weeks.
allison
Does this mean that TNX-901 is now in Phase 3 of the clinical trials or are we still in Phase 2?
I think that the study was moved into phase three but I'm not %100 positive. I know that everyone was re-skin tested and moved up to the optimal dosage according the results of the skin testing. We also signed a new consent form.
Allison
I was told by FAAN that it is actually Xolair that the companies decided to go ahead with into Phase III testing. They said they could begin the peanut allergy testing in Phase III because all the efficacy trials had already been done when it was being tested as an asthma treatment.
Judy